<p>Leprosy is one of the oldest recorded diseases in human history. For thousands of years, it has meant suffering, stigma, and fear. It still affects hundreds of thousands of people globally each year. But one country has now officially left it behind.</p><p>In early March 2026, the <strong>World Health Organization</strong> and the <strong>Pan American Health Organization (PAHO)</strong> formally verified Chile as having <strong>eliminated leprosy as a public health problem</strong> — the first country in the Americas to achieve this status, and only the second country in the world to do so, after Jordan in 2024.</p><h2>What Elimination Actually Means</h2><p>WHO verification requires a country to demonstrate no locally acquired cases for an extended period, alongside robust surveillance systems. Chile last reported a locally acquired case in <strong>1993</strong> — over 30 years ago. The verification involved an independent international commission conducting a rigorous evaluation of Chile's health data, surveillance infrastructure, and capacity to respond to any future cases.</p><p>Crucially, Chile maintained leprosy as a notifiable condition throughout those three decades. The country never stopped watching. And the absence of local transmission was confirmed, year after year, until the numbers were so conclusive that the world's top health body could say: it is done.</p><h2>How Chile Got There</h2><p>Chile's success is attributed to a sustained programme of early detection, free multidrug therapy available to every patient, continuous follow-up care, and comprehensive support for affected individuals. Healthcare workers were trained to recognise early signs. Treatment was provided without charge — removing the financial barrier that allows diseases to persist without diagnosis.</p><p>The programme ran for decades, through multiple governments, without losing momentum. That kind of sustained institutional commitment is rare, and it is what elimination requires.</p><h2>Why This Matters Beyond Chile</h2><p>Leprosy is caused by the bacterium <em>Mycobacterium leprae</em> and remains endemic in parts of South Asia, sub-Saharan Africa, and Brazil. It can be cured with multidrug therapy. But stigma still delays diagnosis in many settings, and late treatment leads to irreversible nerve damage.</p><p>Chile's achievement is proof that elimination is achievable — not just as an aspiration, but as a verified, documented reality. The last locally acquired case: 1993. The world's formal recognition: March 2026.</p><p><em>Sources: World Health Organization (March 4, 2026) · PAHO · Rejoy Health · Development Aid</em></p>
🏥 Health